Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun 6;24(12):9805.
doi: 10.3390/ijms24129805.

P2X7 Receptor and Extracellular Vesicle Release

Affiliations
Review

P2X7 Receptor and Extracellular Vesicle Release

Maria Teresa Golia et al. Int J Mol Sci. .

Abstract

Extensive evidence indicates that the activation of the P2X7 receptor (P2X7R), an ATP-gated ion channel highly expressed in immune and brain cells, is strictly associated with the release of extracellular vesicles. Through this process, P2X7R-expressing cells regulate non-classical protein secretion and transfer bioactive components to other cells, including misfolded proteins, participating in inflammatory and neurodegenerative diseases. In this review, we summarize and discuss the studies addressing the impact of P2X7R activation on extracellular vesicle release and their activities.

Keywords: P2X7 receptor; extracellular vesicles; inflammation; neurodegeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of EV release upon ATP-induced P2X7R activation. Upon ATP stimulation, P2X7R activation induces the recruitment of an Src kinase at the C-terminus of the receptor and the activation of ROCK and p38 MAP kinase triggering cytoskeletal reorganization (i.e., MLC and LIMK) and the translocation of A-SMase to the outer leaflet of the plasma membrane. A-SMase hydrolyzes sphingomyelin to ceramide, facilitating blebs’ formation and large EV shedding (route 1). P2X7R activation and the consequent efflux of K+ also promotes the release of small EVs, generated in the endosomal compartment as ILVs, by inducing NLRP3/ASC/procaspase-1 inflammasome assembling. Inflammasome activation regulates the membrane trafficking pathways that control MVB fusion to the plasma membrane via the cleavage of RILP (route 2). Image created with BioRender.com (accessed on 15 March 2023).
Figure 2
Figure 2
Schematic representation of cytokine processing in EVs upon ATP-induced P2X7R activation. P2X7R activation, by inducing NLRP3 inflammasome assembling, triggers pro-caspase-1 cleavage, which generates active caspase-1 that, in turn, drives the enzymatic activation of the leaderless pro-inflammatory cytokines IL-1β and IL-18. On the other hand, ATP induces TNF packaging into EVs as a transmembrane pro-TNF isoform. Image created with BioRender.com (accessed on 15 March 2023).

References

    1. Steinberg T.H., Newman A.S., Swansonq J.A., Silverstein S.C. ATP4-Permeabilizes the Plasma Membrane of Mouse Macrophages to Fluorescent Dyes. Chemists. 1987;262:88–89. doi: 10.1016/S0021-9258(18)47497-2. - DOI - PubMed
    1. Mutini C., Falzoni S., Ferrari D., Chiozzi P., Morelli A., Baricordi O.R., Collo G., Ricciardi-Castagnoli P., Di Virgilio F. Mouse Dendritic Cells Express the P2X7 Purinergic Receptor: Characterization and Possible Participation in Antigen Presentation. J. Immunol. 1999;163:1958–1965. doi: 10.4049/jimmunol.163.4.1958. - DOI - PubMed
    1. Cockcroft S., Gomperts B.D. ATP induces nucleotide permeability in rat mast cells. Nature. 1979;279:541–542. doi: 10.1038/279541a0. - DOI - PubMed
    1. Visentin S., Renzi M., Frank C., Greco A., Levi G. Two different ionotropic receptors are activated by ATP in rat microglia. J. Physiol. 1999;519:723. doi: 10.1111/j.1469-7793.1999.0723n.x. - DOI - PMC - PubMed
    1. Ferrari D., Pizzirani C., Adinolfi E., Lemoli R.M., Curti A., Idzko M., Panther E., Di Virgilio F. The P2X7 receptor: A key player in IL-1 processing and release. J. Immunol. 2006;176:3877–3883. doi: 10.4049/jimmunol.176.7.3877. - DOI - PubMed

Substances

LinkOut - more resources